StockDriftsStockDriftsTop 31 Venrock Adviser LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 34.18% | 8.49M | $1.13B | +0.00%(+0) | $21.30(+531.69%) | 2026-06-30 | |
| ORKA | ORUKA THERAPEUTICS INC | 11.97% | 4.15M | $394.8M | +0.00%(+0) | $30.35(+270.65%) | 2026-06-30 | |
| ERAS | ERASCA INC | 9.94% | 17.89M | $327.8M | +9.21%(+1.51M) | $3.36(+447.41%) | 2026-06-30 | |
| SYRE | SPYRE THERAPEUTICS INC | 8.04% | 2.99M | $265.0M | -18.99%(-700.00K) | $20.42(+407.54%) | 2026-06-30 | |
| DNTH | DIANTHUS THERAPEUTICS INC | 3.49% | 1.18M | $115.0M | +0.00%(+0) | $24.70(+369.44%) | 2026-06-30 | |
| OCUL | OCULAR THERAPEUTIX INC | 3.08% | 10.35M | $101.6M | +0.00%(+0) | $6.65(+51.04%) | 2026-06-30 | |
| DMRA | DAMORA THERAPEUTICS INC | 2.84% | 3.60M | $93.7M | +0.00%(+0) | $24.45(+25.66%) | 2026-06-30 | |
| SVRA | SAVARA INC | 2.75% | 14.75M | $90.8M | +7.32%(+1.01M) | $2.84(+89.73%) | 2026-06-30 | |
| JBIO | JADE BIOSCIENCES INC | 2.17% | 3.22M | $71.6M | +0.00%(+0) | $49.27(-49.85%) | 2026-06-30 | |
| COGT | COGENT BIOSCIENCES INC | 1.93% | 1.64M | $63.6M | -17.89%(-357.83K) | $8.83(+329.32%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +40.45% | +177.06% | +0.95% | +4.84% |
| Top 20 Holdings Unweighted | +38.54% | +165.88% | +4.15% | +22.57% |
Venrock Adviser LLC reports $3.30B in US-listed equity holdings across 33 positions in its most recent 13F filing. Its largest disclosed positions are APGE (34.2%), ORKA (12.0%) and ERAS (9.9%). The top 20 holdings account for 93.91% of reported assets. Its disclosed equity book has returned +177.06% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Venrock Adviser LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Venrock Adviser LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1615982). View Venrock Adviser LLC’s 13F filings on SEC